Search Results - "Marcus, Pamela M"

Results of the Two Incidence Screenings in the National Lung Screening Trial by Aberle, Denise R, DeMello, Sarah, Berg, Christine D, Black, William C, Brewer, Brenda, Church, Timothy R, Clingan, Kathy L, Duan, Fenghai, Fagerstrom, Richard M, Gareen, Ilana F, Gatsonis, Constantine A, Gierada, David S, Jain, Amanda, Jones, Gordon C, Mahon, Irene, Marcus, Pamela M, Rathmell, Joshua M, Sicks, JoRean

“…An analysis of the results of this trial, which compared low-dose CT with chest radiography, showed that CT had a lower positive predictive value for a…”
Get full text

Targeted Cancer Screening in Average-Risk Individuals by Marcus, Pamela M., PhD, Freedman, Andrew N., PhD, Khoury, Muin J., MD, PhD

“…Targeted cancer screening refers to use of disease risk information to identify those most likely to benefit from screening. Researchers have begun to explore…”
Get full text

Likelihood of missed and recurrent adenomas in the proximal versus the distal colon by Laiyemo, Adeyinka O., MD, MPH, Doubeni, Chyke, MD, MPH, Sanderson, Andrew K., MD, Pinsky, Paul F., PhD, Badurdeen, Dilhana S., MD, Doria-Rose, V. Paul, DVM, PhD, Marcus, Pamela M., PhD, Schoen, Robert E., MD, MPH, Lanza, Elaine, PhD, Schatzkin, Arthur, MD, DrPH, Cross, Amanda J., PhD

“…Background Colonoscopy may be less efficacious in reducing colorectal cancer mortality in the proximal compared with the distal colon. A greater likelihood for…”
Get full text

Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort by Lacey, Jr, James V, Kreimer, Aimee R, Buys, Saundra S, Marcus, Pamela M, Chang, Shih-Chen, Leitzmann, Michael F, Hoover, Robert N, Prorok, Philip C, Berg, Christine D, Hartge, Patricia

“…Multidisciplinary attempts to understand the etiology of breast cancer are expanding to increasingly include new potential markers of disease risk. Those…”
Get full text

Lung Cancer Screening Practices of Primary Care Physicians: Results From a National Survey by Klabunde, Carrie N., PhD, Marcus, Pamela M., PhD, Han, Paul K.J., MD, MA, MPH, Richards, Thomas B., MD, Vernon, Sally W., PhD, Yuan, Gigi, MS, Silvestri, Gerard A., MD, MS

“…Abstract Purpose Although current practice guidelines do not recommend screening asymptomatic patients for lung cancer, physicians may still order lung cancer…”
Get full text

U.S. Primary Care Physicians' Lung Cancer Screening Beliefs and Recommendations by Klabunde, Carrie N., PhD, Marcus, Pamela M., PhD, Silvestri, Gerard A., MD, MS, Han, Paul K.J., MD, MA, MPH, Richards, Thomas B., MD, Yuan, Gigi, MS, Marcus, Stephen E., PhD, Vernon, Sally W., PhD

“…Background No high-quality study to date has shown that screening reduces lung cancer mortality, and expert groups do not recommend screening for asymptomatic…”
Get full text

Hyperplastic Polyps and the Risk of Adenoma Recurrence in the Polyp Prevention Trial by Laiyemo, Adeyinka O, Murphy, Gwen, Sansbury, Leah B, Wang, Zhuoqiao, Albert, Paul S, Marcus, Pamela M, Schoen, Robert E, Cross, Amanda J, Schatzkin, Arthur, Lanza, Elaine

“…Background and Aims Recent studies have suggested that some hyperplastic polyps may be associated with an increased risk of colorectal cancer. Prospective…”
Get full text

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening by Aberle, Denise R, Adams, Amanda M, Berg, Christine D, Black, William C, Clapp, Jonathan D, Fagerstrom, Richard M, Gareen, Ilana F, Gatsonis, Constantine, Marcus, Pamela M, Sicks, JoRean D

“…The National Lung Screening Trial investigators report that persons undergoing three annual screening examinations with low-dose computed tomography had a 20%…”
Get full text

Enrollment of Racial and Ethnic Minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial by Pinsky, Paul F., PhD, Ford, Marvella, PhD, Gamito, Eduard, Higgins, Darlene, Jenkins, Victoria, MEd, Lamerato, Lois, PhD, Tenorio, Sally, Marcus, Pamela M., PhD, Gohagan, John K., PhD

“…Background Minority populations in the United States, especially blacks and Hispanics, are generally underrepresented among participants in clinical trials…”
Get full text

Baseline Chest Radiograph for Lung Cancer Detection in the Randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial by Oken, Martin M., Marcus, Pamela M., Hu, Ping, Beck, Thomas M., Hocking, William, Kvale, Paul A., Cordes, Jill, Riley, Thomas L., Winslow, Stephen D., Peace, Steven, Levin, David L., Prorok, Philip C., Gohagan, John K.

“…Background: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial was initiated in 1992 to examine cause-specific mortality reduction from…”
Get full text

Results of Initial Low-Dose Computed Tomographic Screening for Lung Cancer by Church, Timothy R, Black, William C, Aberle, Denise R, Berg, Christine D, Clingan, Kathy L, Duan, Fenghai, Fagerstrom, Richard M, Gareen, Ilana F, Gierada, David S, Jones, Gordon C, Mahon, Irene, Marcus, Pamela M, Sicks, JoRean D, Jain, Amanda, Baum, Sarah

“…In participants who underwent initial screening in the National Lung Cancer Screening Trial, low-dose CT scanning showed positive results three times as…”
Get full text

Lessons in Medical Record Abstraction from the Prostate, Lung, Colorectal, and Ovarian (PLCO) National Screening Trial by Bazzi, Latifa, Lamerato, Lois E, Varner, Julie, Shambaugh, Vicki L, Cordes, Jill E, Ragard, Lawrence R, Marcus, Pamela M

“…The most rigorous and accurate approach to evaluating clinical events in cancer screening studies is to use data obtained through medical record abstraction…”
Get more information

Recruitment in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial: the First Phase of Recruitment at Henry Ford Health System by Lamerato, Lois E, Marcus, Pamela M, Jacobsen, Gordon, Johnson, Christine Cole

“…Objective: Recruitment of healthy subjects to long-term randomized controlled trials (RCTs) of cancer prevention or early detection has proven to be a…”
Get full text

Patterns of Prostate-Specific Antigen Test Use in the U.S., 2005–2015 by Berkowitz, Zahava, Li, Jun, Richards, Thomas B., Marcus, Pamela M.

“…Recommendations for prostate-specific antigen-based screening for prostate cancer are placing increasing emphasis on men aged 55–69 years. The goal of the…”
Get full text

Data Processing and Analytic Support in the PLCO Cancer Screening Trial by Mabie, Jerome, Riley, Tom, Marcus, Pamela M, Black, Amanda, Rozjabek, Heather, Yu, Kelly, Young, Michael, Austin, Joe, Rathmell, Josh, Williams, Craig, Prorok, Philip C

“…The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial was a large, randomized controlled trial of cancer screening that also evolved over…”
Get more information

Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center by Gren, Lisa H, Lamerato, Lois E, Wright, Patrick, Marcus, Pamela M

“…It is imperative to measure the degree of contamination throughout the course of randomized controlled trials, as contamination, the receipt of the…”
Get more information

Do competing causes of mortality contribute to overdiagnosis in lung cancer screening? by Durham, Danielle D., Croswell, Jennifer M., Marcus, Pamela M.

“…•Death due to causes other than the screen-detected cancer may contribute to overdiagnosis.•Deaths due to non-lung cancer causes soon after screen detection of…”
Get full text

Estimating overdiagnosis in lung cancer screening by Marcus, Pamela M

Get more information

Cancer screening and diagnosis: opportunities for smoking cessation intervention by Land, Stephanie R, Marcus, Pamela M

Get full text

Conceptualizing overdiagnosis in cancer screening by Marcus, Pamela M, Prorok, Philip C, Miller, Anthony B, DeVoto, Emily J, Kramer, Barnett S

“…The aim of cancer screening is to detect asymptomatic cancers whose treatment will result in extension of life, relative to length of life absent screening…”
Get full text